Biopharmaceuticals Industry Analysis—Quantification of Supply and Demand of Manufacturing Capacities

Table of Contents

• EXECUTIVE SUMMARY
  • Executive Summary
    • Executive Summary
  • Industry
    • Industry
  • Capacity Supply and Demand
    • Capacity Supply and Demand
  • Future Prospects
    • Future Prospects
• PROJECT DESIGN
  • Project Design
    • Project Design
  • Purpose and Objective
    • Purpose and Objective
  • Scope of the Project
    • Scope of the Project
• INTRODUCTION TO THE BIOPHARMACEUTICAL INDUSTRY
  • Introduction to the Biopharmaceutical Industry
    • Introduction
  • What are Biopharmaceuticals?
    • What are Biopharmaceuticals?
  • Why Biopharmaceuticals?
    • Why Biopharmaceuticals?
  • Technology
    • Technology
    • Protein Therapeutics
    • Recombinant DNA
    • Monoclonal Antibodies
    • Gene Therapy
    • Antisense Technology
  • Protein Types
    • Protein Types
  • Expression Systems
    • Expression Systems
  • The Manufacturing Process
    • The Manufacturing Process
  • Drug Development and Approval Process
    • Drug Development and Approval Process
    • Pre-clinical Studies
    • Investigational New Drug Application (IND)
    • Clinical Trials Phase I: Safety
    • Phase II Safety and Efficacy
    • Phase III Controlled Safety and Efficacy
  • Approved Therapeutic Products
    • Approved Therapeutic Products
• INDUSTRY OVERVIEW
  • Industry Overview
    • Industry Overview
  • Industry and Competitive Structure
    • Industry and Competitive Structure
    • Research and Development Companies
    • Contract Manufacturing Organizations (CMO)
    • Integrated Biopharmaceuticals Companies
  • Key Market Drivers
    • Key Market Drivers
    • Technological Developments
    • Scientific Data Sharing
    • Financial Profits and Growth
    • FDA Product Approvals
    • Disease Growth
    • Demographic Changes
    • Technology Other Applications
    • New Manufacturing Techniques
    • Globalization
    • Business Opportunities
    • High Exit BarriersCustomers
    • Bio-Terrorism
    • Orphan Drug Statue
  • Key Market Restraints
    • Key Market Restraints
    • Lack of Adequate Funding
    • High Entry Barriers Competitors
    • Clinical Trials and Approval
    • Expensive Drugs
    • Bioinformatics Requirements
    • Negative Perception of Industry
    • Technology Gap
  • Challenges
    • Challenges
    • Manufacturing Capacities
    • Intellectual Property and Patents
    • Moderate Success
    • Health Insurance
    • Information Technology Needs
    • Drug Delivery
    • Human Resources Management
    • Portfolio of Technologies
    • Immediate Economic Conditions
    • Thin Product Lines
    • Late Failure in Clinical Trials
    • New Forms of Diseases
  • Industry Review
    • Global
    • North America
    • Europe
    • Asia
    • Australia
• PRODUCTION CAPACITIES SUPPLY
  • Introduction
    • Introduction
  • Key Market Drivers Of Supply
    • Key Drivers Of Supply
    • Demand for Capacity
    • Drugs in Clinical Trials
    • Expression System Fixed Requirements
    • MAbs and Vaccines Under Developments
    • Key Drug Approvals
    • Cost Advantages and Flexibility
    • Industry Entry Vehicle
    • Growth Vehicle
  • Issues In Capacity - Supply
    • Issues In Capacity - Supply
    • Yields and Runs per Year
    • Biogenerics
    • Globalization
    • Financial Cost of New Facility
    • Long Time Scales
    • Requirements Mismatch
    • Support Functions
    • Employees
    • New Expression Systems Transgenic
    • Previous Experience
  • Assumptions
    • Assumptions
  • Captive Use Manufacturing
    • Captive Use Manufacturing
  • Contract Manufacturing
    • Contract Manufacturing
  • Future Outlook - Industry Supply
    • Future Outlook - Industry Supply
• MARKET FORECASTS - DEMAND
  • Introduction
    • Introduction
  • Key Drivers Of Demand
    • Key Drivers Of Demand
    • Drug Approvals
    • Growth of Diseases
    • Demographic Changes
    • Previously Untreated Patients
    • No Alternative Therapies
    • Monoclonal Antibodies
  • Issues For Capacity Demand
    • Issues For Capacity Demand
    • Unforeseen Demand
    • Global Patent Protection
    • Biogenerics
    • Reactor Volumes
    • Drug Competition
    • FDA Approvals
    • Transgenics
  • Assumptions
    • Assumptions
  • Current Demand
    • Current Demand
  • Future Outlook
    • Future Outlook
• CONCLUSION INDUSTRY CAPACITY
  • Conclusion Industry Capacity
    • Conclusion Industry Capacity
  • Capacity Forecasts
    • Capacity Forecasts
  • Implications
    • Supply of Capacity
    • Demand for Capacity
    • Industry Growth
    • Industry Structure
    • Mergers and Acquisitions
    • Prices
    • The Manufacturing Operations
    • R and D
    • Product Availability
  • SWOT Analysis
    • SWOT Analysis
• FUTURE PROSPECTS
  • Future Prospects
    • Introduction
    • New Products
    • Technology
    • Expression Systems
    • Biogenerics
    • Regulations (U.S FDA)
    • Scenarios
    • Scenario IThe Bioworld
    • Scenario IIThe Rise Of The Clones
    • Conclusion
• APPENDIX
  • List Of Abbreviations
    • List Of Abbreviations
  • Glossary of Terms
    • Glossary of Terms